SCHEMBL24791273

SCHEMBL24791273

C=C(C)OCOC(=O)Nc1ncnn2c([C@]3(/C=N\C)O[C@H](COC(=O)CC4(N)CCCCC4)[C@@H](O)[C@H]3O)ccc12

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TMPRSS2 O15393 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25910238 0.86 TMPRSS2 (0.49) TMPRSS2
SCHEMBL24917653 0.83 TMPRSS2 (0.36) TMPRSS2
SCHEMBL25914178 0.83 TMPRSS2 (0.37) TMPRSS2
SCHEMBL24917346 0.80 TMPRSS2 (0.51) TMPRSS2
SCHEMBL24916920 0.80 TMPRSS2 (0.35) TMPRSS2
SCHEMBL25914244 0.80 TMPRSS2 (0.36) TMPRSS2
SCHEMBL24917313 0.79 TMPRSS2 (0.39) TMPRSS2
SCHEMBL25925794 0.78 TMPRSS2 (0.40) TMPRSS2
SCHEMBL24917069 0.77 TMPRSS2 (0.49) TMPRSS2
SCHEMBL24790460 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022265964-A1 ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS VenatoRx Pharmaceuticals, Inc. (US) 2022-12-22 — — WO disclosed
Send feedback